In terms of specifics, the main finding was that about 28% of patients on ixekizumab alone achieved PASI-100 [a 100% improvement in Psoriasis Area Severity Index score], or complete clearance, and about 40% of patients on the combined drugs achieved complete clearance at the primary end point
Obesity Obesity continues to rise at an alarming rate in the United States and is linked to many serious health conditions, including some of the leading causes of preventable death
Laura Davisson is West Virginia Universitys (WVU) director of Medical Weight Management, a professor, and associate program director for internal medicine
Supply constraints are partly due to Novo Nordisk's single-facility tirzepatide production and Eli Lilly's limited injectable Mounjaro manufacturing footprint
Some studies have found that about half of people who start taking a GLP-1 drug for weight loss stop taking it within a yearfor various reasonsand many people think they can stop taking anti-obesity drugs once theyve reached a desired weight, Oczypok and Anderson write
If you are considering Semaglutide for weight loss, consult with your healthcare provider to discuss whether it is the right option for you and to develop a comprehensive weight management plan tailored to your needs
